The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Artemisinin Derivatives-Global Market Insights and Sales Trends 2025
Synopsis
The global Artemisinin Derivatives market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Artemisinin Derivatives in various end use industries. The expanding demands from the Malaria Treatment, Scientific Research and Others,, are propelling Artemisinin Derivatives market. Dihydroartemisinin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Artemisunate segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Artemisinin Derivatives market, driven by demand from China, the second largest economy with some signs of stabilising, the Artemisinin Derivatives market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Artemisinin Derivatives, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Artemisinin Derivatives market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Artemisinin Derivatives market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Artemisinin Derivatives sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Artemisinin Derivatives covered in this report include Sanofi, KPC Pharmaceuticals, Guangxi Xiancaotang Pharmaceutical, Guilin Pharmaceutical, Kerui Nanhai Pharmaceutical, Shanghai Natural Bio-engineering Co, Novanat Bioresource and Botanical Extracts EPZ Ltd, etc.
The global Artemisinin Derivatives market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
KPC Pharmaceuticals
Guangxi Xiancaotang Pharmaceutical
Guilin Pharmaceutical
Kerui Nanhai Pharmaceutical
Shanghai Natural Bio-engineering Co
Novanat Bioresource
Botanical Extracts EPZ Ltd
Global Artemisinin Derivatives market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Artemisinin Derivatives market, Segment by Type:
Dihydroartemisinin
Artemisunate
Others
Global Artemisinin Derivatives market, by Application
Malaria Treatment
Scientific Research
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Artemisinin Derivatives manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Artemisinin Derivatives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Artemisinin Derivatives market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Artemisinin Derivatives in various end use industries. The expanding demands from the Malaria Treatment, Scientific Research and Others,, are propelling Artemisinin Derivatives market. Dihydroartemisinin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Artemisunate segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Artemisinin Derivatives market, driven by demand from China, the second largest economy with some signs of stabilising, the Artemisinin Derivatives market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Artemisinin Derivatives, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Artemisinin Derivatives market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Artemisinin Derivatives market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Artemisinin Derivatives sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Artemisinin Derivatives covered in this report include Sanofi, KPC Pharmaceuticals, Guangxi Xiancaotang Pharmaceutical, Guilin Pharmaceutical, Kerui Nanhai Pharmaceutical, Shanghai Natural Bio-engineering Co, Novanat Bioresource and Botanical Extracts EPZ Ltd, etc.
The global Artemisinin Derivatives market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
KPC Pharmaceuticals
Guangxi Xiancaotang Pharmaceutical
Guilin Pharmaceutical
Kerui Nanhai Pharmaceutical
Shanghai Natural Bio-engineering Co
Novanat Bioresource
Botanical Extracts EPZ Ltd
Global Artemisinin Derivatives market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Artemisinin Derivatives market, Segment by Type:
Dihydroartemisinin
Artemisunate
Others
Global Artemisinin Derivatives market, by Application
Malaria Treatment
Scientific Research
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Artemisinin Derivatives manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Artemisinin Derivatives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Artemisinin Derivatives Market Overview
1.1 Artemisinin Derivatives Product Overview
1.2 Artemisinin Derivatives Market Segment by Type
1.2.1 Dihydroartemisinin
1.2.2 Artemisunate
1.2.3 Others
1.3 Global Artemisinin Derivatives Market Size by Type
1.3.1 Global Artemisinin Derivatives Market Size Overview by Type (2018-2029)
1.3.2 Global Artemisinin Derivatives Historic Market Size Review by Type (2018-2023)
1.3.3 Global Artemisinin Derivatives Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Artemisinin Derivatives Sales Breakdown by Type (2018-2023)
1.4.2 Europe Artemisinin Derivatives Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Artemisinin Derivatives Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Artemisinin Derivatives Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Artemisinin Derivatives Sales Breakdown by Type (2018-2023)
2 Global Artemisinin Derivatives Market Competition by Company
2.1 Global Top Players by Artemisinin Derivatives Sales (2018-2023)
2.2 Global Top Players by Artemisinin Derivatives Revenue (2018-2023)
2.3 Global Top Players by Artemisinin Derivatives Price (2018-2023)
2.4 Global Top Manufacturers Artemisinin Derivatives Manufacturing Base Distribution, Sales Area, Product Type
2.5 Artemisinin Derivatives Market Competitive Situation and Trends
2.5.1 Artemisinin Derivatives Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Artemisinin Derivatives Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Artemisinin Derivatives as of 2022)
2.7 Date of Key Manufacturers Enter into Artemisinin Derivatives Market
2.8 Key Manufacturers Artemisinin Derivatives Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Artemisinin Derivatives Status and Outlook by Region
3.1 Global Artemisinin Derivatives Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Artemisinin Derivatives Historic Market Size by Region
3.2.1 Global Artemisinin Derivatives Sales in Volume by Region (2018-2023)
3.2.2 Global Artemisinin Derivatives Sales in Value by Region (2018-2023)
3.2.3 Global Artemisinin Derivatives Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Artemisinin Derivatives Forecasted Market Size by Region
3.3.1 Global Artemisinin Derivatives Sales in Volume by Region (2024-2029)
3.3.2 Global Artemisinin Derivatives Sales in Value by Region (2024-2029)
3.3.3 Global Artemisinin Derivatives Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Artemisinin Derivatives by Application
4.1 Artemisinin Derivatives Market Segment by Application
4.1.1 Malaria Treatment
4.1.2 Scientific Research
4.1.3 Others
4.2 Global Artemisinin Derivatives Market Size by Application
4.2.1 Global Artemisinin Derivatives Market Size Overview by Application (2018-2029)
4.2.2 Global Artemisinin Derivatives Historic Market Size Review by Application (2018-2023)
4.2.3 Global Artemisinin Derivatives Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Artemisinin Derivatives Sales Breakdown by Application (2018-2023)
4.3.2 Europe Artemisinin Derivatives Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Artemisinin Derivatives Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Artemisinin Derivatives Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Artemisinin Derivatives Sales Breakdown by Application (2018-2023)
5 North America Artemisinin Derivatives by Country
5.1 North America Artemisinin Derivatives Historic Market Size by Country
5.1.1 North America Artemisinin Derivatives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Artemisinin Derivatives Sales in Volume by Country (2018-2023)
5.1.3 North America Artemisinin Derivatives Sales in Value by Country (2018-2023)
5.2 North America Artemisinin Derivatives Forecasted Market Size by Country
5.2.1 North America Artemisinin Derivatives Sales in Volume by Country (2024-2029)
5.2.2 North America Artemisinin Derivatives Sales in Value by Country (2024-2029)
6 Europe Artemisinin Derivatives by Country
6.1 Europe Artemisinin Derivatives Historic Market Size by Country
6.1.1 Europe Artemisinin Derivatives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Artemisinin Derivatives Sales in Volume by Country (2018-2023)
6.1.3 Europe Artemisinin Derivatives Sales in Value by Country (2018-2023)
6.2 Europe Artemisinin Derivatives Forecasted Market Size by Country
6.2.1 Europe Artemisinin Derivatives Sales in Volume by Country (2024-2029)
6.2.2 Europe Artemisinin Derivatives Sales in Value by Country (2024-2029)
7 Asia-Pacific Artemisinin Derivatives by Region
7.1 Asia-Pacific Artemisinin Derivatives Historic Market Size by Region
7.1.1 Asia-Pacific Artemisinin Derivatives Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Artemisinin Derivatives Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Artemisinin Derivatives Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Artemisinin Derivatives Forecasted Market Size by Region
7.2.1 Asia-Pacific Artemisinin Derivatives Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Artemisinin Derivatives Sales in Value by Region (2024-2029)
8 Latin America Artemisinin Derivatives by Country
8.1 Latin America Artemisinin Derivatives Historic Market Size by Country
8.1.1 Latin America Artemisinin Derivatives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Artemisinin Derivatives Sales in Volume by Country (2018-2023)
8.1.3 Latin America Artemisinin Derivatives Sales in Value by Country (2018-2023)
8.2 Latin America Artemisinin Derivatives Forecasted Market Size by Country
8.2.1 Latin America Artemisinin Derivatives Sales in Volume by Country (2024-2029)
8.2.2 Latin America Artemisinin Derivatives Sales in Value by Country (2024-2029)
9 Middle East and Africa Artemisinin Derivatives by Country
9.1 Middle East and Africa Artemisinin Derivatives Historic Market Size by Country
9.1.1 Middle East and Africa Artemisinin Derivatives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Artemisinin Derivatives Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Artemisinin Derivatives Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Artemisinin Derivatives Forecasted Market Size by Country
9.2.1 Middle East and Africa Artemisinin Derivatives Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Artemisinin Derivatives Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Artemisinin Derivatives Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sanofi Artemisinin Derivatives Products Offered
10.1.5 Sanofi Recent Development
10.2 KPC Pharmaceuticals
10.2.1 KPC Pharmaceuticals Company Information
10.2.2 KPC Pharmaceuticals Introduction and Business Overview
10.2.3 KPC Pharmaceuticals Artemisinin Derivatives Sales, Revenue and Gross Margin (2018-2023)
10.2.4 KPC Pharmaceuticals Artemisinin Derivatives Products Offered
10.2.5 KPC Pharmaceuticals Recent Development
10.3 Guangxi Xiancaotang Pharmaceutical
10.3.1 Guangxi Xiancaotang Pharmaceutical Company Information
10.3.2 Guangxi Xiancaotang Pharmaceutical Introduction and Business Overview
10.3.3 Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Products Offered
10.3.5 Guangxi Xiancaotang Pharmaceutical Recent Development
10.4 Guilin Pharmaceutical
10.4.1 Guilin Pharmaceutical Company Information
10.4.2 Guilin Pharmaceutical Introduction and Business Overview
10.4.3 Guilin Pharmaceutical Artemisinin Derivatives Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Guilin Pharmaceutical Artemisinin Derivatives Products Offered
10.4.5 Guilin Pharmaceutical Recent Development
10.5 Kerui Nanhai Pharmaceutical
10.5.1 Kerui Nanhai Pharmaceutical Company Information
10.5.2 Kerui Nanhai Pharmaceutical Introduction and Business Overview
10.5.3 Kerui Nanhai Pharmaceutical Artemisinin Derivatives Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Kerui Nanhai Pharmaceutical Artemisinin Derivatives Products Offered
10.5.5 Kerui Nanhai Pharmaceutical Recent Development
10.6 Shanghai Natural Bio-engineering Co
10.6.1 Shanghai Natural Bio-engineering Co Company Information
10.6.2 Shanghai Natural Bio-engineering Co Introduction and Business Overview
10.6.3 Shanghai Natural Bio-engineering Co Artemisinin Derivatives Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Shanghai Natural Bio-engineering Co Artemisinin Derivatives Products Offered
10.6.5 Shanghai Natural Bio-engineering Co Recent Development
10.7 Novanat Bioresource
10.7.1 Novanat Bioresource Company Information
10.7.2 Novanat Bioresource Introduction and Business Overview
10.7.3 Novanat Bioresource Artemisinin Derivatives Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Novanat Bioresource Artemisinin Derivatives Products Offered
10.7.5 Novanat Bioresource Recent Development
10.8 Botanical Extracts EPZ Ltd
10.8.1 Botanical Extracts EPZ Ltd Company Information
10.8.2 Botanical Extracts EPZ Ltd Introduction and Business Overview
10.8.3 Botanical Extracts EPZ Ltd Artemisinin Derivatives Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Botanical Extracts EPZ Ltd Artemisinin Derivatives Products Offered
10.8.5 Botanical Extracts EPZ Ltd Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Artemisinin Derivatives Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Artemisinin Derivatives Industrial Chain Analysis
11.4 Artemisinin Derivatives Market Dynamics
11.4.1 Artemisinin Derivatives Industry Trends
11.4.2 Artemisinin Derivatives Market Drivers
11.4.3 Artemisinin Derivatives Market Challenges
11.4.4 Artemisinin Derivatives Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Artemisinin Derivatives Distributors
12.3 Artemisinin Derivatives Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
